BioSpace News Archive

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) today announced that its Chief Executive Officer Jon Congleton and Chief Financial Officer and Chief Business Officer Adam Levy will participate in a fireside chat at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 10, 2023 at 5 p.m. PT

Twist Bioscience Corporation and Aster Insights today announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620 genes associated with cancer.

Sera Prognostics Inc. today announced that it will report first quarter fiscal year 2023 financial results on Wednesday, May 10, 2023, after the close of the market.

Jaguar Health, Inc. announced the results of a survey of 26 U.S. veterinary oncologists regarding Canalevia-CA1, the company’s U.S. Food and Drug Administration conditionally approved prescription drug product for the treatment of chemotherapy-induced diarrhea in dogs.

Perimeter Medical Imaging AI, Inc. announced that it will host an educational symposium featuring the Perimeter S-Series OCT technology at the upcoming annual meeting of the American Society of Breast Surgeons taking place April 26-30, 2023 at the John B. Hynes Veterans Memorial Convention Center in Boston, MA.

Entrinsic Bioscience is pleased to announce the upcoming poster session on the role of Enterade® Advanced Oncology Formula in reducing adverse gastrointestinal side effects for patients undergoing cancer treatment.

Teva Pharmaceutical Industries Ltd. announced that it will host an Investor Day on Thursday, May 18, 2023 to launch its new growth strategy and portfolio priorities.

Capricor Therapeutics announced the publication of a preclinical study in Microbiology Spectrum, a leading peer-reviewed scientific journal of the American Society for Microbiology, highlighting the therapeutic potential of its StealthX™ exosome platform technology to develop a multivalent vaccine against the spike and nucleocapsid SARS-CoV-2 proteins.

Biovica International The shareholders of Biovica International AB, reg. no. 556774-6150, are hereby invited to the extra general meeting to be held on Wednesday 17 May 2023, at 13.00 CET at Baker & McKenzie Advokatbyrå’s premises at Vasagatan 7 in Stockholm.

Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, after the market close.